Aberdeen Group
RGEN icon

Aberdeen Group’s Repligen RGEN Stock Holding History

Aberdeen Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.6M Sell
48,404
-22,091
-31% -$2.71M 0.01% 663
2026
Q1 		$8.31M Buy
70,495
+16,165
+30% +$2.26M 0.01% 622
2025
Q4 		$8.9M Hold
54,330
– – 0.01% 629
2025
Q3 		$7.26M Buy
54,330
+8,152
+18% +$990K 0.01% 652
2025
Q2 		$5.74M Buy
+46,178
New +$5.88M 0.01% 689
2024
Q3 		– Sell
-5,531
Closed -$697K – 957
2024
Q2 		$697K Buy
5,531
+412
+8% +$64.6K ﹤0.01% 839
2024
Q1 		$941K Sell
5,119
-73
-1% -$13.9K ﹤0.01% 827
2023
Q4 		$934K Buy
5,192
+71
+1% +$11.1K ﹤0.01% 842
2023
Q3 		$814K Buy
5,121
+38
+0.7% +$6.21K ﹤0.01% 778
2023
Q2 		$719K Buy
5,083
+1,364
+37% +$219K ﹤0.01% 814
2023
Q1 		$626K Buy
+3,719
New +$664K ﹤0.01% 822

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Aberdeen Group's RGEN Position: Q2 2026 in Review

Aberdeen Group reduced its Repligen (RGEN) stake by 31% in Q2 2026, selling an estimated $2.71M and leaving 48,404 shares worth $6.6M. The position accounts for 0.01% of the portfolio, ranked #663.

Aberdeen Group first reported a position in RGEN in Q1 2023 and has held it in 11 quarters since. The position peaked at $8.9M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Aberdeen Group held 48,404 shares of Repligen worth $6.6M as of Q2 2026.
  • Aberdeen Group sold 22,091 Repligen shares in Q2 2026, an estimated $2.71M.
  • Repligen made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #663 holding.
  • Aberdeen Group first reported a position in Repligen in Q1 2023 and has held it in 11 quarters since.
  • Aberdeen Group's Repligen position peaked at $8.9M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.